Clinical Trial Update: S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing S-1 versus capecitabine in elderly and/or poor performance status patients with recurrent or metastatic gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Stomach Neoplasms | Phase 2 | Status: UNKNOWN